Covered recipient · General Payments record
STEPHANIE BYARD
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2023
$1,033.36
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $416.47 | 22 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $157.78 | 7 |
| Novo Nordisk AS | $70.66 | 4 |
| Exact Sciences Corporation | $43.38 | 3 |
| PFIZER INC. | $37.16 | 2 |
| Amgen Inc. | $33.61 | 2 |
| Nevro Corp. | $23.48 | 1 |
| Acerta Pharma LLC | $18.20 | 1 |
| Lilly USA, LLC | $16.36 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.37 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003298039 | CMS |
| ABBVIE INC. | $31.48 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003298043 | CMS |
| ABBVIE INC. | $13.83 | 07/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003298047 | CMS |
| ABBVIE INC. | $31.64 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003298051 | CMS |
| ABBVIE INC. | $28.22 | 08/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003298055 | CMS |
| ABBVIE INC. | $4.59 | 10/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003298059 | CMS |
| ABBVIE INC. | $29.65 | 10/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003298063 | CMS |
| Amgen Inc. | $16.78 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020804703 | CMS |
| Amgen Inc. | $16.83 | 11/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020804705 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.20 | 02/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014166555 | CMS |
| Exact Sciences Corporation | $14.31 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026780403 | CMS |
| Exact Sciences Corporation | $16.35 | 06/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026780447 | CMS |
| Exact Sciences Corporation | $12.72 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026780467 | CMS |
| Lilly USA, LLC | $16.36 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033652791 | CMS |
| Nevro Corp. | $23.48 | 07/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051686299 | CMS |
| Novo Nordisk Inc | $15.98 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002060353 | CMS |
| Novo Nordisk Inc | $17.44 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002060367 | CMS |
| Novo Nordisk Inc | $23.17 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002060379 | CMS |
| Novo Nordisk Inc | $14.07 | 08/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002060339 | CMS |
| PFIZER INC. | $15.79 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049347097 | CMS |
| PFIZER INC. | $21.37 | 10/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050251755 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.84 | 09/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056570001 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.